Literature DB >> 16290953

Noncompliance in cardiovascular clinical trials.

Victor L Serebruany1, Benjamin R Oshrine, Alex I Malinin, Dan Atar, Alan D Michelson, James J Ferguson.   

Abstract

Mesh：

Year:  2005        PMID： 16290953     DOI： 10.1016/j.ahj.2005.02.039

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  4 in total

1.  The clinical utility of the Medication Adherence Questionnaire (MAQ) in an alcohol pharmacotherapy trial.

Authors:  A Zweben; M E Piepmeier; L Fucito; S S O'Malley
Journal:  J Subst Abuse Treat       Date:  2017-04-04

Review 2.  Nonadherence to treatment protocol in published randomised controlled trials: a review.

Authors:  Susanna Dodd; Ian R White; Paula Williamson
Journal:  Trials       Date:  2012-06-18       Impact factor: 2.279

3.  Comparison of VerifyNow-P2Y12 test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?

Authors:  Cosmo Godino; Loredana Mendolicchio; Filippo Figini; Azeem Latib; Andrew Sp Sharp; John Cosgrave; Giliola Calori; Michela Cera; Alaide Chieffo; Alfredo Castelli; Attilio Maseri; Zaverio M Ruggeri; Antonio Colombo
Journal:  Thromb J       Date:  2009-05-06

Review 4.  A framework for the design, conduct and interpretation of randomised controlled trials in the presence of treatment changes.

Authors:  Susanna Dodd; Ian R White; Paula Williamson
Journal:  Trials       Date:  2017-10-25       Impact factor: 2.279
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.